IRCT20171229038124N1已完成3 期
Evaluation of the Donepezil and Rivastigmine co – administration on the cognitive deficits induced by EcT: A Randomized Double Blind Clinical Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Schizophrenia Disorder
- •Schizoaffective Disorder
- •Bipolar Mood Disorder
- •Major Depressive Disorder
- •ECT 6-12 Sessions
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Effects of Donepezil or Rivastigmine in Patients with idiopathic REM Sleep Behavior Disorder PatientsKCT0004317Keimyung University Dongsan Medical Center100
已完成
4 期
The effect of combination therapy of Donepezil and Memary for moderate to severe Alzheimer's diseasemoderate to severe Alzheimer's diseaseJPRN-UMIN000005883YASUJI YAMAMOTO100
招募中
3 期
Effectiveness of Rivastigmine and Donepezil on cognitive disordersIRCT20210819052232N1Esfahan University of Medical Sciences165
招募中
3 期
Evaluation the effectiveness of rivastigmine and memantine in improving cognitive problems due to electroconvulsive therapyPsychiatric disorders with electroconvulsive therapy (ECT) indication.IRCT20190119042417N2Shahid Beheshti University of Medical Sciences45
招募中
3 期
evaluation of the effect dual combination of Donepezil and Betahistine in improving the symptoms of autism spectrum disorderAutism Spectrum Disorder.Autistic disorderF84.0IRCT20160905029714N2Tehran University of Medical Sciences30